(Source - Pexels)
Healthcare has consistently been one of the top-performing sectors on a risk-adjusted basis throughout the current bull market. During its first half, biotechnology (IBB) and pharmaceuticals (XPH) were all the rage seeing 50% annualized returns per year until the bubble finally ended in 2015. Since then, biotechnology stocks as a whole have gone nowhere. Like a flying billiard ball hitting another, all of that momentum transferred into medical devices (IHI).
The overarching health care narrative is logical. Healthcare is typically less correlated to the general